triazoles has been researched along with Leukemia, Promyelocytic, Acute in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK | 1 |
| Afacan Ozturk, HB; Akyol, P; Albayrak, M; Malkan, UY; Maral, S; Reis Aras, M; Tiglioglu, M; Yilmaz, F | 1 |
| Deng, W; Fan, H; Luo, Q; Wang, H; Zhang, J | 1 |
| Daugelaviciene, V; Kleinotiene, G; Machaczka, M; Posiunas, G; Raistenskis, J; Stankeviciene, S; Zurauskas, E | 1 |
| Cellai, C; Laurenzana, A; Pancrazzi, A; Paoletti, F; Romanelli, MN; Vannucchi, AM | 1 |
| Bennett, MT; Sirrs, S; Smith, CA; Yeung, JK | 1 |
| Anten, S; Heddema, ER; Visser, O; Zweegman, AS | 1 |
| Lohmeyer, M; Workman, P | 1 |
| Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA | 1 |
| Dive, C; Watson, JV; Workman, P | 1 |
| Donaldson, J; Lohmeyer, M; Workman, P | 1 |
11 other study(ies) available for triazoles and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; Tretinoin; Triazoles; Voriconazole; Young Adult | 2022 |
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.
Topics: Female; Humans; Hypercalcemia; Leukemia, Promyelocytic, Acute; Middle Aged; Tretinoin; Triazoles | 2021 |
BRD4 interacts with PML/RARĪ± in acute promyelocytic leukemia.
Topics: Apoptosis; Azepines; Cell Cycle Proteins; Cell Differentiation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Promyelocytic Leukemia Protein; Retinoic Acid Receptor alpha; RNA, Messenger; Transcription Factors; Triazoles; Tumor Cells, Cultured | 2018 |
Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole.
Topics: Absidia; Adolescent; Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia, Promyelocytic, Acute; Lung Diseases, Fungal; Mucormycosis; Pneumonectomy; Triazoles | 2013 |
WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
Topics: Antineoplastic Agents; Apoptosis; Azepines; Caspases; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Receptors, Retinoic Acid; Tretinoin; Triazoles | 2005 |
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Female; Humans; Hypercalcemia; Leukemia, Promyelocytic, Acute; Pyrimidines; Treatment Outcome; Tretinoin; Triazoles; Voriconazole | 2005 |
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Cycle; Cell Division; Cell Membrane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Experimental; Mice; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1995 |
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration | 2001 |
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Division; Cell Membrane Permeability; Flow Cytometry; Furans; Humans; Hydrogen-Ion Concentration; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Animal; Mice; Phospholipid Ethers; Platelet Activating Factor; Time Factors; Triazoles; Tumor Cells, Cultured | 1991 |
Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
Topics: Antineoplastic Agents; Azepines; Calcium; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Furans; Humans; Leukemia, Promyelocytic, Acute; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1991 |